Sigma-Aldrich announced an agreement to supply high quality services and oligonucleotides to Gene Oracle, an innovative gene synthesis company. Under the terms of the agreement, Sigma-Aldrich will be the exclusive supplier of custom oligonucleotides for Gene Oracle, and the two companies will engage in co-marketing efforts to promote the GeneIOS system and their expert gene synthesis services.
The GeneIOS system is unique in the market because it enables researchers to design and create synthetic genes quickly, accurately and at a lower cost than traditional gene synthesis service companies.
"Our partnership with Gene Oracle is focused on providing researchers with an optimal solution for their gene synthesis needs. Sigma-Aldrich has earned the research community's trust with our consistently high quality DNA oligonucleotides that we believe are an ideal complement to Gene Oracle's gene synthesis platform," said Khalil Arar, business development director for Sigma-Aldrich Custom Products. "We are proud to be the exclusive supplier of oligonucleotides to Gene Oracle, and we look forward to building awareness of our joint services through co-marketing efforts."
"Gene Oracle is focused on expanding the use and role of GeneIOS in the gene synthesis market," said Ken Mitchell, chief financial officer of Gene Oracle, "With Sigma-Aldrich's global reach, plus their high quality oligonucleotides, the relationship is expected to provide Gene Oracle with not only strong marketing support but also high quality building blocks for our GeneIOS synthesis solution."
Sigma-Aldrich's oligonucleotides are an integral component of the Gene Oracle gene synthesis platform. After customers design an optimized gene sequence using the GeneIOS software, incorporating desired protein expression and other factors such as protein binding sites, Sigma-Aldrich can generate high quality oligonucleotides that can be easily assembled to create synthetic genes within a single day. Sigma-Aldrich guarantees the quality of its oligonucleotides, making them an ideal component of the GeneIOS solution.
Sigma-Aldrich offers a comprehensive collection of customized oligonucleotide services, from DNA oligos and probes to RNA and siRNA oligos and peptide library synthesis.
Sigma-Aldrich is a leading Life Science and High Technology company. Its chemical and biochemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. Founded in 2004, Gene Oracle Inc. is a privately held Mountain View, California-based corporation focused on developing and commercializing innovative products and services for the life science research market.